Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dalby CK"'
Publikováno v:
Journal for healthcare quality : official publication of the National Association for Healthcare Quality [J Healthc Qual] 2017 Jul/Aug; Vol. 39 (4), pp. e49-e58.
Autor:
Kamal AH; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA arif.kamal@duke.edu., Quinn D; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Gilligan TD; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Davis BC; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Dalby CK; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Bretsch J; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., McNiff KK; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Jacobson JO; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Kamal AH; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA arif.kamal@duke.edu., Quinn D; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Gilligan TD; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Corning Davis B; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Dalby CK; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Bretsch J; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., McNiff KK; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA., Jacobson JO; Duke Cancer Institute, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX; Cleveland Clinic, Cleveland, OH; Partners North Shore Medical Center, Miami, FL; Dana-Farber Cancer Institute, Boston, MA; and American Society of Clinical Oncology, Alexandria, VA.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2016 Feb; Vol. 12 (2), pp. 177; e215-23. Date of Electronic Publication: 2015 Aug 18.
Autor:
Goodman LM; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA goodmal2@ccf.org., Moeller MB; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Azzouqa AG; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Guthrie AE; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Dalby CK; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Earl MA; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Cheng C; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Pennell NA; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Shapiro M; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Velcheti V; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA., Stevenson JP; Cleveland Clinic, Cleveland, OH; and Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2016 Jan; Vol. 12 (1), pp. e101-7.
Autor:
Brooks GA; All authors: Dana-Farber Cancer Institute, Boston, MA., Abrams TA, Meyerhardt JA, Enzinger PC, Sommer K, Dalby CK, Uno H, Jacobson JO, Fuchs CS, Schrag D
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Feb 20; Vol. 32 (6), pp. 496-503. Date of Electronic Publication: 2014 Jan 13.
Autor:
Dalby CK; Dana-Farber Cancer Institute (DFCI), Boston, MA., Nesbitt M, Frechette CA, Kennerley K, Lacoursiere LH, Buswell L
Publikováno v:
Clinical journal of oncology nursing [Clin J Oncol Nurs] 2013 Oct; Vol. 17 (5), pp. 472-5.
Autor:
Rodrigo M; Cardiovascular and Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Mendelsohn L, Bereal-Williams C, Hunter L, Dalby CK, McGowan V 2nd, Hunter CJ, Machado RF, McCoy JP, Cannon RO 3rd, Kato GJ
Publikováno v:
Pulmonary circulation [Pulm Circ] 2013 Apr; Vol. 3 (2), pp. 448-9.
Autor:
Bereal-Williams C, Machado RF, McGowan V 2nd, Chi A, Hunter CJ, Kato GJ, Hunter L, Dalby CK, Hauser KP, Tailor A, Cannon RO 3rd
Publikováno v:
Haematologica [Haematologica] 2012 Nov; Vol. 97 (11), pp. 1768-70. Date of Electronic Publication: 2012 Jul 06.